IgM amyloidosis: Clinical features in therapeutic outcomes

Morie A. Gertz, Francis K. Buadi, Suzanne R. Hayman

Research output: Contribution to journalArticlepeer-review

21 Scopus citations


It is not widely recognized that patients with amyloidosis may be associated with an IgM monoclonal protein. We reviewed the characteristics of 22 IgM amyloidosis patients seen at Mayo Clinic from 1989 through 2010 and uniformly treated with stem cell transplantation. IgM patients are older, have a higher prevalence of neuropathy, a lower incidence of cardiac involvement (lower troponin T and NT-proBNP), and a much lower level of the involved immunoglobulin free light chain.

Original languageEnglish (US)
Pages (from-to)146-148
Number of pages3
JournalClinical Lymphoma, Myeloma and Leukemia
Issue number1
StatePublished - Feb 1 2011

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research


Dive into the research topics of 'IgM amyloidosis: Clinical features in therapeutic outcomes'. Together they form a unique fingerprint.

Cite this